AU3511100A - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
AU3511100A
AU3511100A AU35111/00A AU3511100A AU3511100A AU 3511100 A AU3511100 A AU 3511100A AU 35111/00 A AU35111/00 A AU 35111/00A AU 3511100 A AU3511100 A AU 3511100A AU 3511100 A AU3511100 A AU 3511100A
Authority
AU
Australia
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35111/00A
Inventor
Aris N. Economides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regeneron Pharmaceuticals Inc
Original Assignee
Regeneron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc
Publication of AU3511100A publication Critical patent/AU3511100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
AU35111/00A 1999-03-12 2000-03-02 Novel nucleic acids and polypeptides Abandoned AU3511100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12411899P 1999-03-12 1999-03-12
US60124118 1999-03-12
PCT/US2000/005537 WO2000055193A2 (en) 1999-03-12 2000-03-02 Human dan/cerberus related protein 6 (dcr6)

Publications (1)

Publication Number Publication Date
AU3511100A true AU3511100A (en) 2000-10-04

Family

ID=22412870

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35111/00A Abandoned AU3511100A (en) 1999-03-12 2000-03-02 Novel nucleic acids and polypeptides

Country Status (2)

Country Link
AU (1) AU3511100A (en)
WO (1) WO2000055193A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1857551A3 (en) * 2000-06-01 2007-11-28 Amgen Inc. Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
CA2410912A1 (en) * 2000-06-01 2001-12-06 Amgen, Inc. Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
JP2004520005A (en) * 2000-06-19 2004-07-08 エフ.ホフマン−ラ ロシュ アーゲー Osteolevin gene polymorphism
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
CA2567810A1 (en) 2004-05-27 2005-12-08 Acceleron Pharma Inc. Cerberus/coco derivatives and uses thereof
US9045553B2 (en) 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
EP2099471A2 (en) 2006-12-08 2009-09-16 Acceleron Pharma, Inc. Uses of cerberus, coco and derivatives thereof
WO2018115879A1 (en) 2016-12-21 2018-06-28 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143266A0 (en) * 1998-11-27 2002-04-21 Darwin Discovery Ltd Transforming growth factor-beta binding proteins and pharmaceutical compositions for increasing bone mineral content utilizing the same

Also Published As

Publication number Publication date
WO2000055193A3 (en) 2001-01-18
WO2000055193A2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
EP1242443A4 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2002343417A1 (en) Novel nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001277840A1 (en) Novel nucleic acids and polypeptides
AU5245900A (en) Novel protein and dna thereof
AU3511100A (en) Novel nucleic acids and polypeptides
AU1891301A (en) Novel polypeptide and dna thereof
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2001263005A1 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase